Irinotecan Hydrochloride & Myelosuppression
22.8%
of users reported Myelosuppression
52.3%
also reported Hospitalization
55.4%
are women
Most common medical consequences
Hospitalization
52.3%
Severe reaction
38.5%
Life-threatening condition
7.7%
Disability
1.5%
Have you experienced any negative side effects from this medication?
Irinotecan Hydrochloride: general information
Most common side effects (12)
Most commonly affected ages
30 - 39 years
5.9%
40 - 49 years
4.5%
50 - 59 years
22.0%
60 - 69 years
43.2%
70 - 79 years
24.4%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox